206 related articles for article (PubMed ID: 21199931)
21. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Iacobino A; Giannoni F; Pardini M; Piccaro G; Fattorini L
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010861
[TBL] [Abstract][Full Text] [Related]
22. In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates.
Yip PC; Kam KM; Lam ET; Chan RC; Yew WW
Int J Antimicrob Agents; 2013 Jul; 42(1):96-7. PubMed ID: 23684005
[No Abstract] [Full Text] [Related]
23. First linezolid-resistant clinical isolates of Mycobacterium tuberculosis.
Richter E; Rüsch-Gerdes S; Hillemann D
Antimicrob Agents Chemother; 2007 Apr; 51(4):1534-6. PubMed ID: 17242139
[TBL] [Abstract][Full Text] [Related]
24. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
El-Sayed Zaki M; Goda T
Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
[TBL] [Abstract][Full Text] [Related]
25. A novel agar base medium for drug susceptibility testing of
Coban AY
Future Microbiol; 2021 Sep; 16():949-953. PubMed ID: 34384261
[No Abstract] [Full Text] [Related]
26. In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.
Zhang M; Sala C; Dhar N; Vocat A; Sambandamurthy VK; Sharma S; Marriner G; Balasubramanian V; Cole ST
Antimicrob Agents Chemother; 2014 Jun; 58(6):3217-23. PubMed ID: 24663022
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical Isolates.
AlMatar M; Var I; Kayar B; Eker E; Kafkas E; Zarifikhosroshahi M; Köksal F
Curr Pharm Biotechnol; 2019; 20(4):317-326. PubMed ID: 30854955
[TBL] [Abstract][Full Text] [Related]
28. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
[TBL] [Abstract][Full Text] [Related]
29. Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco.
Chaoui I; Sabouni R; Kourout M; Jordaan AM; Lahlou O; Elouad R; Akrim M; Victor TC; El Mzibri M
J Infect Dev Ctries; 2009 May; 3(4):278-84. PubMed ID: 19759491
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
Chen L; Li N; Liu M; Zhang J; Zhang H
J Antimicrob Chemother; 2011 Oct; 66(10):2435-7. PubMed ID: 21795258
[No Abstract] [Full Text] [Related]
31. Tuberculosis drug resistance in Canakkale, Turkey.
Gonlugur T; Basol G; Gonlugur U
Cent Eur J Public Health; 2020 Sep; 28(3):245. PubMed ID: 32997482
[No Abstract] [Full Text] [Related]
32. In vitro activity of linezolid against Mycobacterium tuberculosis strains isoalted from Western Turkey.
Ermertcan S; Hosgor-Limoncu M; Erac B; Tasli H; Cavusoglu C; Bozkurt H
Jpn J Infect Dis; 2009 Sep; 62(5):384-5. PubMed ID: 19762990
[TBL] [Abstract][Full Text] [Related]
33. Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs.
Rüsch-Gerdes S; Domehl C; Nardi G; Gismondo MR; Welscher HM; Pfyffer GE
J Clin Microbiol; 1999 Jan; 37(1):45-8. PubMed ID: 9854062
[TBL] [Abstract][Full Text] [Related]
34. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
[TBL] [Abstract][Full Text] [Related]
35. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
36. Combinatory activity of linezolid and levofloxacin with antituberculosis drugs in Mycobacterium tuberculosis.
Santos NCS; Scodro RBL; de Almeida AL; Baldin VP; Nakamura de Vasconcelos SS; Siqueira VLD; Caleffi-Ferracioli KR; Campanerut-Sá PAZ; Cardoso RF
Tuberculosis (Edinb); 2018 Jul; 111():41-44. PubMed ID: 30029913
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC
Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195
[TBL] [Abstract][Full Text] [Related]
38. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z
Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours.
Kirk SM; Schell RF; Moore AV; Callister SM; Mazurek GH
J Clin Microbiol; 1998 Jun; 36(6):1568-73. PubMed ID: 9620378
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to front line antituberculosis drugs and comparison with the radiometric BACTEC 460 TB method].
Sinirtaş M; Ozakin C; Gedikoğlu S
Mikrobiyol Bul; 2009 Jul; 43(3):403-9. PubMed ID: 19795615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]